WARRANT FRIULCHEM S.P.A. 2019-2022” – ISIN IT0005378366 CHIUSURA DEL TERZO E ULTIMO PERIODO DI ESERCIZIO 1-30 NOVEMBRE 2022
THE CERTIFICATION OF CONFORMITY TO THE RULES OF GOOD MANUFACTURING OF MEDICINAL PRODUCTS FOR VETERINARY USE FOR THE ITALIAN MARKET HAS BEEN RENEWED
FRIULCHEM OBTAINED THE RENEWAL OF FOOD SAFETY SYSTEM CERTIFICATION (FSSC) 22000 AND UNI ISO 45001: 2018
FRIULCHEM SIGNS AN AGREEMENT WITH AN ITALIAN PHARMACEUTICAL COMPANY
CFO SIM BEGINS HEDGING OF FRIULCHEM SHARE WITH BUY AND TP RECOMMENDATION € 1.80 PER SHARE
FRIULCHEM OTTIENE DUE NUOVE CERTIFICAZIONI: FOOD SAFETY SYSTEM CERTIFICATION (FSSC) 22000 PER LA PREPARAZIONE DI MISCELE PER ADDITIVI IN POLVERE E COMPRESSE MASTICABILI PER IL BENESSERE DEGLI ANIMALI E FAMI-QS PER LA COMMERCIALIZZAZIONE DI SPECIALTY FEED
Friulchem participates in the 3rd edition of the China International Import Expo
ACCORDO DI LICENZA E COMMERCIALIZZAZIONE CON APTA MEDICA INTERNACIONAL D.O.O. PER L’EST EUROPA
ACCORDO DI LICENZA E COMMERCIALIZZAZIONE CON APTA MEDICA INTERNACIONAL D.O.O. PER L’EST EUROPA
FRIULCHEM OBTAINS AUTHORISATION FOR PATENT EXTENSION IN FRANCE RELATED TO FC-CUBES CHEWABLE TABLETS
Friulchem S.p.A. is pleased to announce that it has obtained authorization of a new patent application in France for chewable tablets, soon to be extended to other EU and non-EU countries.